Literature DB >> 16566961

Vitamin D: its role in cancer prevention and treatment.

Michael F Holick1.   

Abstract

Vitamin D, the sunshine vitamin, has been recognized for almost 100 years as being essential for bone health. Vitamin D provides an adequate amount of calcium and phosphorus for the normal development and mineralization of a healthy skeleton. Vitamin D made in the skin or ingested in the diet, however, is biologically inactive and requires obligate hydroxylations first in the liver to 25-hydroxyvitamin D, and then in the kidney to 1,25-dihydroxyvitamin D. 25-Hydroxyvitamin D is the major circulating form of vitamin D that is the best indicator of vitamin D status. 1,25-dihydroxyvitamin D is the biologically active form of vitamin D. This lipid-soluble hormone interacts with its specific nuclear receptor in the intestine and bone to regulate calcium metabolism. It is now recognized that the vitamin D receptor is also present in most tissues and cells in the body. 1,25-dihydroxyvitamin D, by interacting with its receptor in non-calcemic tissues, is able to elicit a wide variety of biologic responses. 1,25-dihydroxyvitamin D regulates cellular growth and influences the modulation of the immune system. There is compelling epidemiologic observations that suggest that living at higher latitudes is associated with increased risk of many common deadly cancers. Both prospective and retrospective studies help support the concept that it is vitamin D deficiency that is the driving force for increased risk of common cancers in people living at higher latitudes. Most tissues and cells not only have a vitamin D receptor, but also have the ability to make 1,25-dihydroxyvitamin D. It has been suggested that increasing vitamin D intake or sun exposure increases circulating concentrations of 25-hydroxyvitamin D, which in turn, is metabolized to 1,25-dihydroxyvitamin D(3) in prostate, colon, breast, etc. The local cellular production of 1,25-dihydroxyvitamin D acts in an autocrine fashion to regulate cell growth and decrease the risk of the cells becoming malignant. Therefore, measurement of 25-hydroxyvitamin D is important not only to monitor vitamin D status for bone health, but also for cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566961     DOI: 10.1016/j.pbiomolbio.2006.02.014

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  69 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

2.  UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control study.

Authors:  L Grandin; L Orsi; X Troussard; A Monnereau; C Berthou; P Fenaux; G Marit; P Soubeyran; F Huguet; N Milpied; M Leporrier; D Hemon; J Clavel
Journal:  Cancer Causes Control       Date:  2007-11-27       Impact factor: 2.506

3.  Double-dose vitamin D lowers cancer risk in women over 55.

Authors:  Sarah-Anne Schumann; Bernard Ewigman
Journal:  J Fam Pract       Date:  2007-11       Impact factor: 0.493

4.  Vitamin D supplementation: Recommendations for Canadian mothers and infants.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-09       Impact factor: 2.253

Review 5.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

Review 6.  Not enough vitamin D: health consequences for Canadians.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

7.  Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.

Authors:  Julia A Newton-Bishop; Samantha Beswick; Juliette Randerson-Moor; Yu-Mei Chang; Paul Affleck; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Linda Whitaker; Sharon Jackson; Edwina Gerry; Clarissa Nolan; Chandra Bertram; Jerry Marsden; David E Elder; Jennifer H Barrett; D Timothy Bishop
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.

Authors:  Timothy M Chlon; David A Taffany; Joellen Welsh; Matthew J Rowling
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

9.  Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women.

Authors:  Angela K Green; Susan E Hankinson; Elizabeth R Bertone-Johnson; Rulla M Tamimi
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

Review 10.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.